About the Event

The ALS Bike Trek MN is a charity bike ride created by ALS TDI to raise awareness of ALS and funding toward an effective treatment. The eighth annual ALS Bike Trek Minnesota is directed and chaired by Justin Rumley in memory of his father Steve (aka Buckwheat) Rumley who lost his courageous battle to ALS in November 2009. Justin is also the creator of The Buckwheat, a gastric feeding tube designed to allow single hand operation to enable ALS patients, like Justin's father, to continue employing their limited independence as long as possible. Justin is a passionate and driven supporter who is committed to finding a way to end this disease. To date, this event has raised over $736,000 for ALS research!

Team Mustang

We are pleased to announce this year's Honorary Co-Chair, Gary Bolenbaugh. His family's known history of ALS goes back generations. Most recently his sister was diagnosed at age 63. The impact on his family continues to be very detrimental and he looks to the day when a cure for ALS will be found. When Gary first heard of the ALS Bike Trek MN, he immediately jumped on board to help in any way possible.

Previous Honorary Co-Chairmen include Bob Stimson, Michael Winston, Michael Brandt, Steve Lufkin and Jone See. To read more about Bob, Michael, Michael, Steve and Jone please click here.

All proceeds will go to Augie's Quest at the ALS Therapy Development Institute and the Muscular Dystrophy Association.


Augie's Quest by ALS TDI

Augie's Quest by ALS TDI

The goal of Augie's Quest has always been to fund research and drug development aimed at ending ALS through a huge network of national events, promotions, family, and friends. Since 2007, Augie's Quest has raised nearly $40 million dollars in support of finding effective treatments, making it the largest individual fundraising program for ALS! All funds raised by Augie's Quest benefit ALS TDI, the world's largest ALS-dedicated drug discovery organization. Founded in 1999, the ALS Therapy Development Institute (ALS TDI) has invested $100 million in drug development for ALS patients today. With 25 drug development experts working tirelessly in a 26,000 square foot facility located in Cambridge, MA, ALS TDI is the world's leader in ALS research. A 501(c)(3) nonprofit biotech, ALS TDI is dedicated to expediting promising potential treatments from lab bench to people living with this disease as quickly as possible. To learn more about Augie's Quest and ALS TDI, visit www.augiesquest.org and www.als.net.


MDA

MDA

The Muscular Dystrophy Association (MDA) is the world's leading nonprofit health agency dedicated to finding treatments and cures for muscular dystrophy, amyotrophic lateral sclerosis (ALS) and other neuromuscular diseases. It does so by funding worldwide research; by providing comprehensive health care services and support to MDA families nationwide; and by rallying communities to fight back through advocacy, fundraising and local engagement. Visit mda.org and follow us at facebook.com/mdaminnesota and @ncs_mda.